Open AccessRole of γ-glutamyl transferase levels in prediction of high cardiovascular risk among patients with non-alcoholic fatty liver disease
Author(s) -
Benan Kasapoğlu,
Cansel Türkay,
Kadir Serkan Yalçın,
Ayşe Çarlıoğlu,
Aslı Köktener
Publication year - 2016
Publication title -
indian journal of medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.578
H-Index - 87
ISSN - 0971-5916
DOI - 10.4103/0971-5916.178585
Subject(s) - fatty liver , medicine , framingham risk score , gastroenterology , liver function tests , liver function , disease , uric acid , ferritin , diabetes mellitus , risk factor , endocrinology
Non-alcoholic fatty liver disease (NAFLD) is an important cause of elevated liver functions. There is evidence showing an association between NAFLD and subclinical atherosclerosis independent of traditional risk factors. We undertook this retrospective study to determine the association of Framingham cardiovascular risk scoring system with liver function tests and inflammatory markers and to find the role of liver function tests in determination of CVD risk among non-obese and non-diabetic subjects with non-alcoholic fatty liver disease.